Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, and Cytokines

When:  Mar 10, 2023 from 14:00 to 18:00 (CT)
This program will be hybrid. Please attend in-person or virtually!


Adi Diab, MD - The University of Texas MD Anderson Cancer Center
Greg Lizee, PhD - The University of Texas MD Anderson Cancer Center
Rahul A. Sheth, MD - The University of Texas MD Anderson Cancer Center

Program Purpose

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading authorities in tumor immunology and cancer immunotherapy, at the conclusion of this activity, participants of this should be able to:

  • Describe the mechanisms of intratumoral therapies, vaccines, and cytokines.
  • Summarize recent updates in the use of intratumoral therapies, vaccines, and cytokines clinically.
  • Outline common toxicities with intratumoral therapies, vaccines and cytokines and their management.
Attendees will also have an opportunity for connecting with experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.

For more information on the program, click below.


View the SITC Meeting Code of Conduct.


Hilton Houston Plaza/Medical Center
6633 Travis St
Houston, TX 77030